Nurse-led telephone of nausea and vomiting in cancer patients undergoing antineoplastic chemotherapy with Cisplatin
Cisplatin is an antineoplastic used in treatment of some types of cancer. However, approximately 70 to 80% of patients undergoing this treatment are at risk of nausea and vomiting. Objective: Monitoring the occurrence of nausea and vomiting in cancer patients submitted to antineoplastic chemotherapy with cisplatin from the first treatment session.